Epalinges, Switzerland

Daryl Reed


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Daryl Reed: Innovator in Cancer Research

Introduction

Daryl Reed is a prominent inventor based in Epalinges, Switzerland. He has made significant contributions to the field of cancer research, particularly in the development of immunogenic compositions related to tumor rejection antigens.

Latest Patents

Daryl Reed holds 5 patents that focus on innovative approaches to cancer treatment. His latest patents include immunogenic compositions of tumor rejection antigen precursor MAGE-10 and an adjuvant. These patents encompass isolated cDNA molecules that encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and various uses of these inventions. Additionally, he has developed MAGE-10 encoding cDNA, antibodies specific to the molecule, and their applications.

Career Highlights

Daryl Reed is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer immunology. His work has been instrumental in understanding and developing therapies that target specific tumor antigens.

Collaborations

Daryl has collaborated with notable colleagues in his field, including Donata Rimoldi and Victor Jongeneel. Their combined expertise has contributed to the success of various research initiatives.

Conclusion

Daryl Reed's innovative work in cancer research and his contributions to the development of immunogenic compositions highlight his role as a leading inventor in the field. His patents and collaborations continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…